Article

Boston Micromachines product earns most innovative product for 2007

Watertown, MA-The editors of R&D magazine and Micro/Nano newsletter recognized Boston Micromachines' latest version of its Multi-DM as one of the most innovative products of 2007.

Watertown, MA-The editors of R&D magazine and Micro/Nano newsletter recognized Boston Micromachines' latest version of its Multi-DM as one of the most innovative products of 2007.

The magazine and newsletter recognize Boston Micromachines for its innovation in developing a deformable mirror that is used for ultra high resolution retinal imaging which is necessary for the early detection of ocular disease.

The 25 awards are given to the developers of the most innovative and most groundbreaking products, processes, inventions, discoveries or innovations in micro- and nanotechnology in the past year and those having the largest impact on specific industry or society in general.

Boston Micromachines' new mirror has an increased stroke while maintaining high resolution. The mirror can provide high speed real-time imaging with a 5mm aperture perfectly suited for a dilated pupil.

The Multi-DM will also enhance other biological imaging areas. Biological imaging instruments can suffer from resolution limitations, constraining the ability of researchers and clinicians to detect critical detail.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.